FIELD: medicine.
SUBSTANCE: method includes definition of target HLA immunotypr, mitotic activation of unfertilised diploid oocytes after meiosis 1 by means of calcium ionophore for development blastocyst masses, each of them contains internal cellular mass (ICM), homozygous on target HLA immunotype, allocation of homozygous stem cells from ICM, plating of these cells for obtaining of lines of cells and selection of cells, homozygous on target HLA immunotype. The way obtaining of bank of these cells obtained from many donors is also described.
EFFECT: advantage of the invention lies in possibility of obtaining of considerable quantity of histocompatible cells for transplantation.
10 cl, 4 ex, 11 dwg
Title | Year | Author | Number |
---|---|---|---|
PATIENT-SPECIFIC STEM CELL LINES DERIVED FROM HUMAN PARTHENOGENETIC BLASTOCYSTS | 2008 |
|
RU2511418C2 |
PARTHENOGENETIC ACTIVATION OF HUMAN OOCYTES FOR PRODUCING HUMAN EMBRYONAL STEM CELLS | 2006 |
|
RU2469085C2 |
ISOLATED HOMOZYGOUS STEM CELL (VARIANTS), METHOD FOR ITS PREPARING (VARIANTS), METHOD FOR PREPARING REQUIRED CELL-ANCESTOR, DIFFERENTIATED CELL, GROUP OF DIFFERENTIATED CELLS OR TISSUE TYPE | 2001 |
|
RU2322497C2 |
METHOD OF OBTAINING CLONED REPRESENTATIVE OF CANINE FAMILY | 2006 |
|
RU2391817C2 |
METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
METHOD FOR TREATING CHRONIC HEPATITISES OR HEPATIC CIRRHOSIS CASES | 2006 |
|
RU2295351C1 |
METHOD FOR PREPARING CELLS FOR REPLACEMENT CELL THERAPY OF HEPATIC PATHOLOGY | 2012 |
|
RU2510276C1 |
TRANSGENIC HOOFED ANIMALS, HAVING LOWER ACTIVITY OF PRION PROTEIN, AND THEIR APPLICATIONS | 2003 |
|
RU2384059C2 |
METHOD OF PRODUCING INDUCED PLURIPOTENT STEM CELLS FROM FIBROBLASTS OF PATIENTS WITH HUNTINGTON'S DISEASE | 2011 |
|
RU2458983C1 |
METHOD FOR DETERMINING POSTTRANSPLANTATION CHIMERISM IN ANALYSIS OF POINT MUTATIONS OF BASE SUBSTITUTION IN GENES F2, F5, F7, F13, FGB, ITGA2, ITGB3, PAI-1 | 2017 |
|
RU2667006C1 |
Authors
Dates
2008-11-20—Published
2002-01-02—Filed